Status:
COMPLETED
ERAS for Patients Received Neoadjuvant Chemotherapy
Lead Sponsor:
JIANG Zhi-Wei
Conditions:
Gastric Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Patients received neoadjuvant chemotherapy with locally advanced gastric caner undergo the enhanced recovery after surgery (ERAS) programs or the standard cares (SC) programs.
Detailed Description
Before, most trials about the ERAS for radical gastrectomy demonstrated ERAS programs accelerate the postoperative rehabilitation of gastric cancer patients without increasing postoperative complicati...
Eligibility Criteria
Inclusion
- Patients received neoadjuvant chemotherapy with locally advanced gastric cancer.
- Age older than 18 and younger than 75 years.
- American Society of Anesthesiologists (ASA) class: I-III.
- Participants can describe the symptom objectively and cooperate actively.
- Written informed consent.
Exclusion
- Patients allergic to oxaliplatin, tegafur gimerac etc.
- Patients with ischemic heart disease, cerebrovascular disease and peripheral vascular disease, or cardiac function \> II (NYHA)
- Patients with complications (bleeding, perforation and obstruction) caused by gastric cancer.
- Patients with severe liver and renal dysfunction (Child - Pugh ≥ 10; Cr \< 25 ml/min).
- Patients who require simultaneous surgery for other diseases.
- Patients who received upper abdominal surgery previously.
- Pregnant or breast-feeding women.
Key Trial Info
Start Date :
April 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 6 2017
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT03272984
Start Date
April 1 2015
End Date
July 6 2017
Last Update
September 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling Hospital, Medical School of Nanjing University
Nanjing, Jiangsu, China, 210002